Single Arm Phase II Clinical Trial to Investigate the Efficacy and Safety of Apatinib as a Single Agent in Advanced Non-squamous Non-small Cell Lung Cancer Patients Who Failed to Previous at Least 3rd Line Treatments.
Phase of Trial: Phase II
Latest Information Update: 06 Aug 2015
At a glance
- Drugs Apatinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 06 Aug 2015 New trial record